The bottleneck of biomanufacturing
Synthetic biology (or “synbio”) is the design and engineering of biological systems to create components that do not already exist in the natural world. We believe this is the decade of biology but challenges, particularly around the nascent infrastructure, need to be overcome for it to fulfil its promise.
Companies that care: Lessons from a unicorn founder and his purpose-driven investor
Doing good may also be a good investment—and potentially transformative for the world. Two leaders on the front lines discuss the current landscape and what’s next.
Q&A with angel investor Tommy Stadlen
The most successful start-ups are often those that divide early opinion. It’s difficult — and vital — to reject groupthink and Fomo when picking investments.
Silicon Valley faces a revolt after losing public trust
Technology executives risk attracting an opprobrium often reserved for bankers.
Companies must clean up their act or the scandals will continue
Businesses must engage with societal demands.
Climate skeptics
Every successful advertising executive understands that effective campaigns offer the promise of a better, more attractive life. Yet climate change communications remain stuck in the dark ages, attempting to scare and shock the public into action.